Ye, Z., Zeng, Y., Wei, S., Wang, Y., Lin, Z., Chen, S., . . . Chen, L. (2021). Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer. BMC Cancer.

Ye, Zaisheng, Yi Zeng, Shenghong Wei, Yi Wang, Zhitao Lin, Shu Chen, Zhiwei Wang, Shanshan Chen, und Luchuan Chen. "Short-term Survival and Safety of Apatinib Combined With Oxaliplatin and S-1 in the Conversion Therapy of Unresectable Gastric Cancer." BMC Cancer 2021.

Ye, Zaisheng, et al. "Short-term Survival and Safety of Apatinib Combined With Oxaliplatin and S-1 in the Conversion Therapy of Unresectable Gastric Cancer." BMC Cancer 2021.